RICOVR Healthcare, based in Princeton, NJ, is the creator of the XALIVA™ rapid diagnostics platform that provides high-quality, rapid diagnostic results using only a small amount of saliva. The company’s product pipeline includes rapid point-of-care tests for THC, drugs-of-abuse, and infectious diseases. RICOVR is proud to be guided by a distinguished advisory board and management team of scientists and engineers committed to making a positive impact on society. In addition, the company has strong partnerships with leading research institutions and medical device manufacturing companies around the globe. RICOVR’s testing platform leverages the first truly portable nanoparticle detection technology, allowing for fast, non-invasive specimen collection and analytics. With the collaboration of industry experts, the company’s platform is versatile and already expanding into new point-of-care diagnostics including drugs-of-abuse and infectious disease testing. RICOVR is driven by the belief that a more accurate and cost-effective solution should be available for employers, law enforcement, healthcare systems and others relying on fast and reliable access to data. RICOVR team includes experts across medical device design and manufacturing, leadership, sales, medicine, technology, and scientific research to deliver on your needs today and tomorrow.